Anti-TNF therapeutics have been used as a first-line biological treatment of a variety of inflammatory diseases, including rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD) (3–5). The gene discussed is TNF; the disease is rheumatoid arthritis.